The effects of methylene blue on renal scarring due to pyelonephritis in rats

Burhan Aksu1, Mustafa Inan, Mehmet Kanter

  • 1Department of Pediatric Surgery, Faculty of Medicine, Trakya University, Edirne, Turkey. burhanfeyza@yahoo.com

Insights

Methylene blue (MB) may help prevent kidney scarring from pyelonephritis (PNP) when added to delayed antibiotic treatment. This combination showed reduced scarring compared to antibiotics alone in a rat model.

Area of Science:

  • Nephrology
  • Pharmacology
  • Infectious Diseases

Background:

  • Pyelonephritis (PNP) can lead to renal scarring, especially with delayed treatment.
  • Oxidative damage contributes to tissue injury in PNP.
  • Methylene blue (MB) has shown antioxidant properties.

Purpose of the Study:

  • To assess the efficacy of methylene blue (MB) in preventing renal scarring post-pyelonephritis (PNP) in rats.
  • To evaluate MB's role when combined with delayed antimicrobial therapy.

Main Methods:

  • Induction of PNP in rats using Escherichia coli.
  • Treatment groups: untreated, ciprofloxacin (CIP) alone, MB alone, and MB + CIP, all with delayed therapy initiation.
  • Biochemical and histopathological examination of kidneys for renal scarring at six weeks.

Main Results:

  • Significant reduction in renal scarring observed in groups treated with MB (alone or with CIP) compared to untreated or CIP-only groups.
  • Delayed antibiotic therapy alone did not significantly impact scarring.
  • MB addition to delayed antibiotic therapy showed potential benefits.

Conclusions:

  • Methylene blue (MB) may be beneficial in preventing renal scarring associated with pyelonephritis (PNP).
  • Combining MB with delayed antibiotic therapy could mitigate PNP-induced oxidative renal damage.